Skip to main content

Clinical trial Talapro-3

Talapro-3: A Phase 3, Randomized, Double-Blind, Study Of Talazoparib With Enzalutamide Versus Placebo With Enzalutamide In Men With Ddr Gene Mutated Metastatic Castration-Sensitive Prostate Cancer

Cancers
Organ prostate
Trial status Trial closed for recruitment
Investigator
Trial type
Interventional with experimental drug
Phase Trial phase 3
Academic trial Non
Sponsor Pfizer
EudraCT Identifier 2021-000248-23
ClinicalTrials.gov https://clinicaltrials.gov/ct2/show/NCT04821622
Last update